Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()

Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient underg...

Descripción completa

Detalles Bibliográficos
Autores principales: Turíbio, Débora Dorneles Cunha de Queiroz, Oliveira, Francisco Clitson Sousa, Barreto, Sandra Maria Fonseca, Jabour, Thaís Barros Felippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245706/
https://www.ncbi.nlm.nih.gov/pubmed/34001401
http://dx.doi.org/10.1016/j.abd.2020.08.016
_version_ 1783716166723698688
author Turíbio, Débora Dorneles Cunha de Queiroz
Oliveira, Francisco Clitson Sousa
Barreto, Sandra Maria Fonseca
Jabour, Thaís Barros Felippe
author_facet Turíbio, Débora Dorneles Cunha de Queiroz
Oliveira, Francisco Clitson Sousa
Barreto, Sandra Maria Fonseca
Jabour, Thaís Barros Felippe
author_sort Turíbio, Débora Dorneles Cunha de Queiroz
collection PubMed
description Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis.
format Online
Article
Text
id pubmed-8245706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-82457062021-07-02 Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()() Turíbio, Débora Dorneles Cunha de Queiroz Oliveira, Francisco Clitson Sousa Barreto, Sandra Maria Fonseca Jabour, Thaís Barros Felippe An Bras Dermatol Case Report Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis. Sociedade Brasileira de Dermatologia 2021 2021-05-15 /pmc/articles/PMC8245706/ /pubmed/34001401 http://dx.doi.org/10.1016/j.abd.2020.08.016 Text en © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Turíbio, Débora Dorneles Cunha de Queiroz
Oliveira, Francisco Clitson Sousa
Barreto, Sandra Maria Fonseca
Jabour, Thaís Barros Felippe
Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title_full Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title_fullStr Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title_full_unstemmed Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title_short Interstitial lung disease due to anti-TNF use in the treatment of psoriasis()()
title_sort interstitial lung disease due to anti-tnf use in the treatment of psoriasis()()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245706/
https://www.ncbi.nlm.nih.gov/pubmed/34001401
http://dx.doi.org/10.1016/j.abd.2020.08.016
work_keys_str_mv AT turibiodeboradornelescunhadequeiroz interstitiallungdiseaseduetoantitnfuseinthetreatmentofpsoriasis
AT oliveirafranciscoclitsonsousa interstitiallungdiseaseduetoantitnfuseinthetreatmentofpsoriasis
AT barretosandramariafonseca interstitiallungdiseaseduetoantitnfuseinthetreatmentofpsoriasis
AT jabourthaisbarrosfelippe interstitiallungdiseaseduetoantitnfuseinthetreatmentofpsoriasis

Ejemplares similares